血红蛋白总量在运动员生物护照兴奋剂检测中的意义

doi:10.12047/j.cjap.5701.2018.116

中国应用生理学杂志 ›› 2018, Vol. 34 ›› Issue (6): 519-523.doi: 10.12047/j.cjap.5701.2018.116

血红蛋白总量在运动员生物护照兴奋剂检测中的意义

汪军¹, 张美玲¹, 王松利¹, 刘敏¹, Yannis Pitisladis²

1. 北京体育大学, 北京 100084;
2. The Brighton Centre for Regenerative Medicine (BCRM), University of Brighton, Hillbrow, Denton Road, Eastbourne BN20 7SR, UK

收稿日期:2018-04-26 修回日期:2018-11-16 出版日期:2018-11-28 发布日期:2019-03-09
通讯作者: 汪军 E-mail:wj430079@126.com
基金资助:
北京体育大学冰雪运动一带一路联合实验室；2018年北京体育大学国际合作课题（2018GJ006）；2018年科技部冬奥公关课题（2018YFF0300801）

The research of hemoglobin mass on athletic biological passport for blood doping detection

WANG Jun¹, ZHANG Mei-ling¹, WANG Song-li¹, LIU Min¹, YANNIS Pitisladis²

1. Department of Exercise Physiology, Beijing Sport University, Beijing 100084, China;
2. The Brighton Centre for Regenerative Medicine(BCRM), University of Brighton, Hillbrow, Denton Road, Eastbourne, BN20 7SR, UK

Received:2018-04-26 Revised:2018-11-16 Online:2018-11-28 Published:2019-03-09
Supported by:
北京体育大学冰雪运动一带一路联合实验室；2018年北京体育大学国际合作课题（2018GJ006）；2018年科技部冬奥公关课题（2018YFF0300801）

摘要/Abstract

摘要： 目的：观察注射微量重组人促红细胞生成素（rHuEPO）后，受试者在不同时间段血液某些参数指标的变化，为兴奋剂rHuEPO检测运动员生物护照（ABP）提供实验依据。方法：采用单盲方式对14名健康青年男性受试者进行两个阶段随机安慰剂（n=14）和微量rHuEPO（n=14）皮下注射，每阶段7周，每周2次。EPO注射期间给予每天口服铁剂105 mg；在注射前第7日、第一次注射后第3、10、17、24、31、38和45日、以及第7周最后一次注射后第7、14、21日分别采取静脉血测试血液基础参数（红细胞、血红蛋白浓度[Hb]、红细胞压积、网织红细胞），改良一氧化碳（CO）吸入法测试血红蛋白总量（tHb）以及全血量（BV）、血浆量（PV）的变化情况；分析这些指标在ABP中的使用，观察总量指标和浓度指标在检测中的有效性和时效性。结果：与安慰剂组相比，14名受试者在微量rHuEPO注射后第2周，即开始出现红细胞数量和[Hb]增加，在注射期间第5~6周达到高峰（分别增加9%和10%左右，P<0.01），一直持续到最后一次注射后3周左右；tHb在注射后1周即开始增加，5周达到最高峰（增加10%左右，P<0.01）并一直持续到最后一次注射后1周才开始逐级恢复到注射前水平；红细胞总量在实验第5周上升至峰值，幅度为10.89%（P<0.01），总血量（BV）变化不明显，血浆量（PV）出现下降，血液浓缩。结论：7周微量rHuEPO注射可以显著增加血液总量指标和浓度指标，其中血红蛋白总量更加敏感，可以用ABP血红蛋白总量等监测微量EPO注射；在最后一次注射结束后，血液总量指标如血红蛋白总量恢复正常，而浓度指标仍保持较高水平，可能是血液浓缩的结果。

关键词: rHuEPO注射, 血红蛋白总量, 血红蛋白浓度, 生物护照, 兴奋剂

Abstract: Objective: To research the changes of blood parameters on different time points after micro-rHuEPO injection on young men and hope to provide evidences for Athletic Biological Passport (ABP) using in the detection of blood doping.Methods: Fourteen health young men were injected with micro-rHuEPO for 7 weeks, twice per one week.The subjects were treated with ferralia 105 mg every day during the injections.The control group was administrated with the same volume of saline solution injection and placebo 105 mg.The blood parameters (red blood cell, hemoglobin, reticulocyte, total hemoglobin, plasma volume, etc) were tested 11 times (7 days before the first injection, 3, 10, 17, 24, 31, 38 and 45 days after the first injection, 1, 2 and 3 weeks post the seventh week of last injection).By analyzed these total and concentration parameters, hope to know the effective of two kinds of parameters on ABP.Results: The levels of RBC and[Hb] were increased sharply after two weeks of injection and reached the peak in 5-6 weeks (9-10%, P<0.01).It sustained till 3 weeks after the last injection.Total hemoglobin was increased significantly during the whole procedure of injections and reached the peak in week 5 (10%, P<0.01) till 1 week after the last injection.Red blood cell volume was increased with the EPO injection and reached the peak in week 5 (P<0.01), but blood volume wasn't increased significantly.Plasma volume was decreased with EPO injection and it was hemoconcentration.Conclusion: It can enhance the total and concentration parameters through 7-week micro-rHuEPO injections and the total haemoglobin is more sensitive.So tHb can be used to detect blood doping in ABP.At the end of the last injection, the total blood parameters, such as the total hemoglobin, returned to normal, while the concentration index remained highly, possibly as a result of blood concentration.

Key words: micro-rHuEPO injections, total hemoglobin, hemoglobin concentration, athletic biological passport, doping

汪军, 张美玲, 王松利, 刘敏, Yannis Pitisladis. 血红蛋白总量在运动员生物护照兴奋剂检测中的意义[J]. 中国应用生理学杂志, 2018, 34(6): 519-523.

WANG Jun, ZHANG Mei-ling, WANG Song-li, LIU Min, YANNIS Pitisladis. The research of hemoglobin mass on athletic biological passport for blood doping detection[J]. CJAP, 2018, 34(6): 519-523.

参考文献

[1] WADA. WADA Athlete Biological Passport Operating Guidelines[S]. version 2.1, 2010.
[2] Schumacher YO,d'Onofrio G. Scientific expertise and the athlete biological passport:3 years of experience[J]. Clin Chem, 2012, 58(6):979-985.
[3] Schumacher YO, Saugy M, Pottgiesser T, et al. Detection of EPO doping and blood doping:the haematological module of the athlete biological passport[J]. Drug Test Anal, 2012, 4(11):846-853.
[4] Zorzoli M, Rossi F. Case studies on ESA-doping as revealed by the biological passport[J]. Drug Test Anal, 2012, 4(11):854-858.
[5] Koehler K, Braun H, de Marees M, et al. Urinary excretion of exogenous glycerol administration at rest[J]. Drug Test Anal, 2011, 3(11-12):877-882.
[6] Schmidt W, Prommer N. The optimised CO-rebreathing method:a new tool to determine total haemoglobin mass routinely[J]. Eur J Appl Physiol, 2005, 95(5-6):486-495.
[7] Prommer N, Sottas PE, Schoch C, et al. Total hemoglobin mass-a new parameter to detect blood doping[J]? Med Sci Sports Exerc, 2008, 40(12):2112-2118.
[8] Burge CM, Skinner SL. Determination of hemoglobin mass and blood volume with CO:evaluation and application of a method[J]. J Appl Physiol, 1995, 79(2):623-631.
[9] Madeddu C, Gramignano G, Astara G, et al. Pathogenesis and treatment options of cancer related anemia:perspective for a targeted mechanism-based approach[J]. Front Physiol, 2018, 9:1294.
[10] Eggold JT, Rankin EB. Erythropoiesis, EPO, macrophages, and bone[J]. Bone, 2019, 119:36-41.
[11] Beliaev AM, Allen SJ, Milsom P, et al. Low-dose erythropoietin treatment is not associated with clinical benefits in severely anaemic Jehovah's Witnesses:a plea for a change[J]. Blood Transfus, 2018, 16(1):53-62.
[12] Birkeland KI, Stray-Gundersen J, Hemmersbach P, et al. Effect of rhEPO administration on serum levels of sTfR and cycling performance[J]. Med Sci Sports Exerc, 2000, 32(7):1238-1243.
[13] Beliaev AM, Allen SJ, Milsom P, et al. Low-dose erythropoietin treatment is not associated with clinical benefits in severely anaemic Jehovah's Witnesses:a plea for a change[J]. Blood Transfus, 2018, 16(1):53-62.
[14] Ashenden M, Gough CE, Garnham A, et al. Current markers of the Athlete Blood Passport do not flag microdose EPO doping[J]. Eur J Appl Physiol, 2011, 111(9):2307-2314.
[15] Sanchis-Gomar F, Martinez-Bello VE, Gomez-Cabrera MC, et al. The hybrid algorithm (Hbmr) to fight against blood doping in sports[J]. Scand J Med Sci Sports, 2010, 20(6):789-790.
[16] Parisotto R, Gore CJ, Emslie KR, et al. A novel method utilising markers of altered erythropoiesis for the detection of recombinant human erythropoietin abuse in athletes[J]. Haematologica, 2000, 85(6):564-572.
[17] Schumacher YO, Wenning M, Robinson N, et al. Diurnal and exercise-related variability of haemoglobin and reticulocytes in athletes[J]. Int J Sports Med, 2010, 31(4):225-230.
[18] Schmidt W, Prommer N. Effects of various training modalities on blood volume[J]. Scand J Med Sci Sports, 2008, 18(Suppl 1):57-69.
[19] Durussel J, Daskalaki E, Anderson M, et al. Haemoglobin mass and running time trial performance after recombinant human erythropoietin administration in trained men[J]. PLoS One, 2013, 8(2):e56151.

血红蛋白总量在运动员生物护照兴奋剂检测中的意义

The research of hemoglobin mass on athletic biological passport for blood doping detection

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 0

编辑推荐

Metrics

本文评价